AAAAAA
Results:
1-11
|
Results: 11
Authors:
Hupperets, PSGJ
Wils, JAJM
Volovics, L
Schouten, LJ
Fickers, MMF
Bron, HNLM
Jager, JJ
de Jong, JMA
Blijham, GH
Citation: Psgj. Hupperets et al., Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) for node-positive cancer patients, update at 12 years follow up, BREAST, 10(1), 2001, pp. 35-37
Authors:
Langendijk, JA
Aaronson, NK
de Jong, JMA
ten Velde, GPM
Muller, MJ
Lamers, RJ
Slotman, BJ
Wouters, EFM
Citation: Ja. Langendijk et al., Prospective study on quality of life before and after radical radiotherapyin non-small-cell lung cancer, J CL ONCOL, 19(8), 2001, pp. 2123-2133
Authors:
van der Toom, PPG
Veltman, JA
Bot, FJ
de Jong, JMA
Manni, JJ
Ramaekers, FCS
Hopman, AHN
Citation: Ppg. Van Der Toom et al., Mapping of resection margins of oral cancer for p53 overexpression and chromosome instability to detect residual (pre)malignant cells, J PATHOLOGY, 193(1), 2001, pp. 66-72
Authors:
Langendijk, JA
Aaronson, NK
ten Velde, GPM
de Jong, JMA
Muller, MJ
Wouters, EFM
Citation: Ja. Langendijk et al., Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy, ACTA ONCOL, 39(8), 2000, pp. 949-958
Authors:
Langendijk, H
Aaronson, NK
de Jong, JMA
ten Velde, GPM
Muller, MJ
Wouters, M
Citation: H. Langendijk et al., The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy, RADIOTH ONC, 55(1), 2000, pp. 19-25
Authors:
Zwingmann, IH
Welle, IJ
Engelen, JJM
Schilderman, PAEL
de Jong, JMA
Kleinjans, JCS
Citation: Ih. Zwingmann et al., Analysis of oxidative DNA damage and HPRT mutant frequencies in cancer patients before and after radiotherapy, MUT RES-F M, 431(2), 1999, pp. 361-369
Authors:
Remarque, EJ
de Jong, JMA
van der Klis, RJ
Masurel, N
Lighthart, GJ
Citation: Ej. Remarque et al., Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients, EXP GERONT, 34(1), 1999, pp. 109-115
Authors:
Verdonck-de Leeuw, IM
Keus, RB
Hilgers, FJM
Koopmans-van Beinum, FJ
Greven, AJ
de Jong, JMA
Vreeburg, G
Bartelink, H
Citation: Im. Verdonck-de Leeuw et al., Consequences of voice impairment in daily life for patients following radiotherapy for early glottic cancer: Voice quality, vocal function, and vocalperformance, INT J RAD O, 44(5), 1999, pp. 1071-1078
Authors:
Jager, JJ
Volovics, L
Schouten, LJ
de Jong, JMA
Hupperets, PSGJ
von Meyenfeldt, MF
Schutte, B
Blijham, GH
Citation: Jj. Jager et al., Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation, RADIOTH ONC, 50(3), 1999, pp. 267-275
Authors:
Verdonck-de Leeuw, IM
Hilgers, FJM
Keus, RB
Koopmans-van Beinum, FJ
Greven, AJ
de Jong, JMA
Vreeburg, G
Bartelink, H
Citation: Im. Verdonck-de Leeuw et al., Multidimensional assessment of voice characteristics after radiotherapy for early glottic cancer, LARYNGOSCOP, 109(2), 1999, pp. 241-248
Authors:
Langendijk, JA
Tjwa, MKT
de Jong, JMA
ten Velde, GPM
Wouters, EFM
Citation: Ja. Langendijk et al., Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?, RADIOTH ONC, 49(2), 1998, pp. 175-183
Risultati:
1-11
|